National Cancer Institute; Notice of Closed Meeting, 11248 [05-4498]

Download as PDF 11248 Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Health Professions Preparatory, Health Professions Pregraduate and Indian Health Professions Scholarship Programs; Correction ACTION: Notice; correction. SUMMARY: The Indian Health Service published a document in the Federal Register on January 19, 2005. The document contained one error. FOR FURTHER INFORMATION CONTACT: Mr. Jess Brien, Chief, Scholarship Branch, Indian Health Service, 801 Thompson Avenue, Suite 120, Rockville, Maryland 20852; telephone 301–443–6197. (This is not a toll-free number.) Correction In the Federal Register of January 19, 2005, in FR Doc. 05–1030, on page 3046, in the second column, correct the Application Review Date to read April 18–April 22, 2005. Dated: February 28, 2005. Robert G. McSwain, Deputy Director, Indian Health Service. [FR Doc. 05–4479 Filed 3–7–05; 8:45 am] Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Mary C. Fletcher, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Rm 8115, Bethesda, MD 20892, (301) 496–7413. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS.) Dated: March 1, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–4498 Filed 3–7–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–16–M National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee E—Cancer Epidemiology, Prevention & Control. Date: April 6–8, 2005. Time: 7 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Sepsis and CAP: Partnerships for Diagnostics Development. Date: March 21–22, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Stefani T. Rudnick, PhD, Scientific Review Administrator, Scientific PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550, srudnick@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Hepatitis C Cooeprative Research Centers. Date: March 23–25, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–435– 2766, gm145a@nih.gov. Name of Committee: National Institutes of Allergy and Infectious Diseases Special Emphasis Panel Novel HIV Therapeutics: Integrated Preclinical/Clinical Program (IPCP). Date: March 23–25, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Tracy A. Shahan, PhD, Scientific Review Adminsitrator, Scientific Review Program, Divison of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, 301–496–2606, tshahan@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Disorders of Therapeutic Immunosuppression. Date: March 23, 2005. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, 3147, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Duane Price, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 6700B, Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550; dprice@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Emphasis Panel ‘‘Animal Models for the Prevention and Treatment of Hepatitis B and Hepatitis C.’’ Date: March 24, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Lucy A. Ward, DVM, Scientific Review Administrator, Scientific Review Program, Division of Extramual Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, Room 3117, Bethesda, MD 20892–7616, (301) 496–2550; lw275a@nih.gov. E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Notices]
[Page 11248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4498]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee E--Cancer Epidemiology, Prevention & Control.
    Date: April 6-8, 2005.
    Time: 7 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Mary C. Fletcher, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Rm 8115, Bethesda, 
MD 20892, (301) 496-7413.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS.)

    Dated: March 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-4498 Filed 3-7-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.